NCT04165681

Brief Summary

Depression, the most common mental health disorder among adolescents, is a critical health problem within the US. In this study, the feasibility, acceptability, and preliminary efficacy of Limbix Spark, a cognitive behavioral therapy (CBT)- based mobile app + virtual reality (VR) program for helping adolescents live well with depression will be investigated. This program is specifically designed around behavioral activation theory, the idea that completing activities that make a patient feel pleasure or provide a sense of mastery are effective in reducing symptoms of depression. The program involves the use of both VR and a mobile app that include CBT components like psychological assessments, psychoeducation, and skills training. 30 participants aged 12-21 years old with mild to severe depressive symptoms and smartphone access will be enrolled in this study. The primary efficacy outcome measures will be depressive symptoms with anxiety symptoms, functional outcomes, and dimensional scales of positive and negative affect and behavioral activation serving as secondary outcome measures. Qualitative and quantitative feedback on the use of the VR + mobile app (ease of use, comfort, willingness to use again) will be assessed using questionnaires. Engagement and adherence to the program will be assessed by assessing VR and app usage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 11, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2020

Completed
Last Updated

July 7, 2020

Status Verified

July 1, 2020

Enrollment Period

5 months

First QC Date

November 11, 2019

Last Update Submit

July 6, 2020

Conditions

Keywords

AdolescenceCognitive Behavioral TherapyVirtual RealityDepressionBehavioral Activation

Outcome Measures

Primary Outcomes (2)

  • Adherence to program

    % of enrolled participants completing all sessions at post treatment

    Post treatment (5 weeks)

  • Change in depression post treatment

    Change in depressive symptoms measured by Personal Health Questionnaire (PHQ-8) (min: 0; max: 24, with higher score indicating more severe depression).

    Change from Baseline to Post treatment (5 weeks)

Secondary Outcomes (1)

  • Change in depression at one month follow up

    Change from Baseline to 1 month follow up (9 weeks)

Study Arms (1)

Limbix Spark

EXPERIMENTAL

A 5 week mobile + virtual reality CBT-based program

Other: Limbix Spark

Interventions

5-week, self-guided mobile + VR CBT-based program for adolescent depression

Limbix Spark

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Score of 10 or greater on Patient Health Questionnaire (PHQ-8)
  • English fluency and literacy
  • Access to a smart phone
  • Patient willing to provide informed consent/assent and have parent/guardian willing to provide informed consent if under 18.

You may not qualify if:

  • Seizure disorder or other neurological disorder
  • Prior diagnosis of or receiving treatment for substance use disorder, bipolar disorder, or psychosis
  • Significant vision or hearing impairment
  • Hospitalized or received residential/inpatient treatment for a suicide attempt or self-harming behaviors within the past 3 months
  • Current diagnosis of a reading/learning or intellectual disability.
  • Receiving treatment (including but not limited to medication or psychotherapy) for a cognitive disorder, including attention deficit hyperactivity disorder (ADHD).
  • Are currently participating in a treatment study.
  • Pregnancy
  • History of significant motion sickness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Limbix Health, Inc.

Los Angeles, California, 90266-2558, United States

Location

Related Publications (1)

  • Miller I, Peake E, Strauss G, Vierra E, Koepsell X, Shalchi B, Padmanabhan A, Lake J. Self-Guided Digital Intervention for Depression in Adolescents: Feasibility and Preliminary Efficacy Study. JMIR Form Res. 2023 Nov 22;7:e43260. doi: 10.2196/43260.

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Jessica Lake, PhD

    Director of Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2019

First Posted

November 18, 2019

Study Start

October 12, 2019

Primary Completion

March 19, 2020

Study Completion

April 17, 2020

Last Updated

July 7, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations